Loading...
Loading...
Among the 8 tracked institutional investors we monitor, SUPN (SUPERNUS PHARMACEUTICALS) is held with a combined value of $1.29B across 25,211,043 shares. The largest holder is BlackRock, Inc. with a position worth $454.73M (0.01% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 5 funds increased their holdings. 2 funds reduced their position.
Total Institutional Value
$1.29B
Total Shares Held
25,211,043
Institutional Holders
8
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $454.73M | 0.01% | +0.7% |
| 2 | VANGUARD GROUP INC | $300.61M | 0.00% | New |
| 3 | MILLENNIUM MANAGEMENT LLC | $171.40M | 0.07% | +23.5% |
| 4 | STATE STREET CORP | $118.27M | 0.00% | +3.1% |
| 5 | RENAISSANCE TECHNOLOGIES LLC | $88.14M | 0.14% | -1.6% |
| 6 | CITADEL ADVISORS LLC | $78.98M | 0.01% | +219.1% |
| 7 | Point72 Asset Management, L.P. | $68.16M | 0.09% | -41.8% |
| 8 | FMR LLC | $10.82M | 0.00% | +68.4% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of SUPN with a position worth $454.73M, representing 0.01% of their portfolio. In total, 8 institutional investors hold SUPN with a combined value of $1.29B.
In the most recent quarter, 1 fund opened a new position in SUPN. Additionally, 5 increased their holdings and 2 reduced their positions.
Institutional investors hold $1.29B worth of SUPN stock across 8 positions. The largest institutional holder is BlackRock, Inc. with $454.73M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For SUPN, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their SUPN positions.